About this trial
Gastrointestinal polyps (GIPs) are unusual growths of epithelial tissue projecting from the mucosa of gastrointestinal tract (GIT) and one of the most common pathologies affecting GIT . They are either proliferative or neoplastic mucosal lesions that are commonly seen in the colon and less commonly occur in the esophagus, stomach and small intestine. They may remain asymptomatic or present as bleeding, pain and obstruction due to mass effect. However, the most important risk with the gastrointestinal polyps is the development of malignancy in some of these polyps . Gastric polyps include hyperplastic, fundic gland polyps, inflammatory fibroid polyp, adenomas like pyloric gland adenoma, and oxyntic gland adenoma. Hyperplastic gastric polyps rarely undergo neoplastic progression (1.5-2.1%) but are associated with an increased risk of synchronous cancer occurring elsewhere in the gastric mucosa . Gastric adenomas are true neoplasms and precursors of gastric cancer. Adenomas larger than 20 mm in width and villous histology have a higher risk of neoplastic progression . The presence of gastric adenomas is strongly associated with synchronous or metachronous gastric adenocarcinoma . Polyps of the small bowel are rare compared to those of the colo-rectum, with adenomas being most common and having more preference for the distal duodenum, ampullary, and periampullary region Colonic Polyps may be classified according to their gross appearance (sessile or pedunculated), histopathological features (hyperplastic, adenoma, etc.), and behavior (benign or malignant). The biggest concern is their ability to progress into adenocarcinoma, through the adenoma to carcinoma sequence due to genetic mutation .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Patients with insufficient data were excluded
Trial population
This cross-sectional study will be conducted on all specimens with gastrointestinal polyps referred to the pathology Laboratories at ElRajhy hospital and surgical pathology lab in Assuit University Hospital during the period from January 2022 to December 2024 after approval of the committee of ethics of scientific research in Faculty of Medicine in Assuit University. The data will be collected from registers, medical files and reports from pathological department of Assiut University Hospital.Slides will be reviewed with Haematoxylin-Eosin stain to determinethe type of the polyps.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
To assess the presence and grade of dysplasia either low grade or high grade dysplasia in all examined polyps.
To assess the presence and grade of dysplasia either low grade or high grade dysplasia in all examined polyps.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: